Who are Pain Relief Ointment's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Qutenza Patch, Relief Pro cream, Capsaicine low dose 0.04 %, Capsaicin Topical Cream, Topical analgesic, Capsaicin 8%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/pain-relief-ointment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Pain Relief Ointment — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Relief Ointment (Pain Relief Ointment) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical analgesic. Area: Pain Management.

marketed Topical analgesic Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Pain Relief Ointment (Pain Relief Ointment) — Johnson & Johnson Consumer and Personal Products Worldwide. Pain Relief Ointment provides topical analgesia by delivering active ingredients through the skin to reduce localized pain and inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Pain Relief Ointment TARGET	Pain Relief Ointment	Johnson & Johnson Consumer and Personal Products Worldwide	marketed	Topical analgesic
Qutenza Patch	Qutenza Patch	M.D. Anderson Cancer Center	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)
Relief Pro cream	Relief Pro cream	Bayer	marketed	Topical analgesic
Capsaicine low dose 0.04 %	Capsaicine low dose 0.04 %	University Hospital, Clermont-Ferrand	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)
Capsaicin Topical Cream	Capsaicin Topical Cream	Women and Infants Hospital of Rhode Island	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)
Topical analgesic	Topical analgesic	Grünenthal GmbH	marketed	Topical analgesic
Capsaicin 8%	Capsaicin 8%	Averitas Pharma, Inc.	marketed	Topical analgesic; TRPV1 agonist	TRPV1 (transient receptor potential vanilloid 1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical analgesic class)

Bayer · 1 drug in this class
EpiCept Corporation · 1 drug in this class
Express Specialty Pharmacy · 1 drug in this class
Georg Kägi, MD · 1 drug in this class
Grünenthal GmbH · 1 drug in this class
Henry Ford Health System · 1 drug in this class
Johnson & Johnson Consumer and Personal Products Worldwide · 1 drug in this class
NeurogesX · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Pain Relief Ointment — Competitive Intelligence Brief. https://druglandscape.com/ci/pain-relief-ointment. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab